Revolutionising Endometriosis Diagnosis
Empowering women and healthcare professionals with fast, non-invasive, and insightful solutions.
Because women have waited long enough for better answers.
Contact us
Endometriosis Diagnosis is Broken
Current methods are invasive, costly, and unreliable.
Millions suffer in silence due to outdated diagnostic approaches.
6 - 12 years
Average wait before an endometriosis diagnosis
1 in 10 women
Suffer from endometriosis
30% of women
Are likely to experience severe pelvic pain
AUD 8.9 billion
Annual economic burden in Australia
A New Era in Endometriosis Diagnosis
EXONOVA Biotech is developing a non-invasive blood-based test powered by advanced biomarkers.
Our technology provides nuanced results, helping clinicians make better treatment decisions.
Our approach aims to reduce unnecessary surgeries, speed up diagnosis, and give women more control over their care.
Enhanced Patient Journey
Symptoms
GP Visit
Sample Collection
Exonova Test
Informed Decision
Better for Women,
Smarter for Clinicians &
Cheaper for Everyone.
Women
- Shorter diagnostic time
- Fewer unnecessary surgeries
- More informed choices
- Reduced suffering
Clinicians
- Clearer patient triage
- Objective results
- Enhanced decision-making
- Improved patient outcomes
Healthcare Systems
- Reduced surgical load
- Optimised resources
- Lower costs
- Patient prioritisation
Current vs. Enhanced Pathway
Current pathway
Exonova-enhanced
Diagnosis Time
Surgery Rate
Patient Satisfaction
Healthcare Costs
Our Vision
Diagnosis
Deliver highly accurate and rapid results to empower doctors in providing better care for women
Research & Development
Advance the understanding of endometriosis to unlock new diagnostic and treatment opportunities
Personalised Treatment
Develop tailored therapies based on individual patient profiles
Get in touch
Whether you are a clinician or a partner eager to collaborate, we will be happy to hear from you.
Email us